cholangitis

13
Cholangitis

description

Cholangitis  Cholangitis  Clinical manifestations  Diagnosis  Treatment  Case Case Ampullary cancer Pancreatic cancer Ascaris lumbricoides Porta hepatis Sclerosing cholangitis Strictures/stenosis                 Gallstones more common in women  M: F ratio equal in cholangitis  Age  Sex  Median age between 50-60  Elderly patients more likely to progress from asymptomatic gallstones to cholangitis without colic

Transcript of cholangitis

Page 1: cholangitis

Cholangitis

Page 2: cholangitis

Content Case

Cholangitis Clinical manifestations Diagnosis Treatment

Page 3: cholangitis

Case HPI:

Patient p/w 3-4 episodes of RUQ/mid-epigastric abdominal pain over the last year, lasting generally several hours, accompanied by occasional emesis, anorexia, and sensation of shaking chills.

ROS: negative otherwise PE:

VS: T 36.2, P98 , RR 18, BP 124/64 Abdominal exam significant for RUQ TTP

Labs AST 553, ALT 418. Alk Phos 466. Bilirubin 2.7 WBC 30.3

Imaging Abdominal US: multiple gallstones, no pericholecystic fluid, no

extrahepatic/intrahepatic/CBD dilatation

Page 4: cholangitis

Introduction Cholangitis is bacterial infection superimposed on biliary obstruction

First described by Jean-Martin Charcot in 1850s as a serious and life-threatening illness

Causes Choledocholithiasis Obstructive tumors

Pancreatic cancer Cholangiocarcinoma Ampullary cancer Porta hepatis

Others Strictures/stenosis ERCP Sclerosing cholangitis AIDS Ascaris lumbricoides

Page 5: cholangitis

Epidemiology Internationally:

Oriental cholangiohepatitis endemic in SE Asia- recurrent pyogenic cholangitis with intrahepatic/extrahepatic stones in 70-80%

Gallstones highest in N European descent, Hispanic populations, Native Americans

Intestinal parasites common in Asia

Sex Gallstones more common in

women M: F ratio equal in

cholangitis Age

Median age between 50-60 Elderly patients more likely

to progress from asymptomatic gallstones to cholangitis without colic

Page 6: cholangitis

Pathogenesis Normally, bile is sterile due to constant flush,

bacteriostatic bile salts, secretory IgA, and biliary mucous; Sphincter of Oddi forms effective barrier to duodenal reflux and ascending infection

ERCP or biliary stent insertion can disrupt the Sphincter of Oddi barrier mechanism, causing pathogeneic bacteria to enter the sterile biliary system.

Obstruction from stone or tumor increases intrabiliary pressure

High pressure diminishes host antibacterial defense- IgA production, bile flow- causing immune dysfunction, increasing small bowel bacterial colonization.

Bacteria gain access to biliary tree by retrograde ascent

Biliary obstruction (stone or stricture) causes bactibilia E Coli (25-50%) Klebsiella (15-20%), Enterobacter (5-10%)

High pressure pushes infection into biliary canaliculi, hepatic vein, and perihepatic lymphatics, favoring migration into systemic circulation- bacteremia (20-40%).

Adam.about.com

Gpnotebook.co.uk Pathology.med.edu

Page 7: cholangitis

Clinical Manifestations RUQ pain (65%) Fever (90%)

May be absent in elderly patients Jaundice (60%) Hypotension (30%) Altered mental status (10%)

Charcot’s Triad:Found in 50-70% of patients

Reynold’s Pentad:

Additional HistoryPruitus, acholic stoolsPMH for gallstones, CBD stones, Recent ERCP, cholangiogram

Additional Physical TachycardiaMild hepatomegaly

Page 8: cholangitis

Diagnosis: lab values CBC

79% of patients have WBC > 10,000, with mean of 13,600 Septic patients may be neutropenic

Metabolic panel Low calcium if pancreatitis 88-100% have hyperbilirubinemia 78% have increased alkaline phosphatase AST and ALT are mildly elevated

Aminotransferase can reach 1000U/L- microabscess formation in the liver

GGT most sensitive marker of choledocholithiasis Amylase/Lipase

Involvement of lower CBD may cause 3-4x elevated amylase Blood cultures

20-30% of blood cultures are positive

Page 9: cholangitis

Diagnosis: first-line imagingUltrasonography Advantage:

Sensitive for intrahepatic/extrahepatic/CBD dilatation CBD diameter > 6 mm on US associated with high prevalence of choledocholithaisis Of cholangitis patients, dilated CBD found in 64%,

Rapid at bedside Can image aorta, pancreas, liver Identify complications: perforation, empyema, abscess

Disadvantage Not useful for choledocholithiasis:

Of cholangitis patients, CBD stones observed in 13% 10-20% falsely negative - normal U/S does not r/o cholangitis

acute obstruction when there is no time to dilate Small stones in bile duct in 10-20% of cases

CT Advantages

CT cholangiograhy enhances CBD stones and increases detection of biliary pathology Sensitivity for CBD stones is 95%

Can image other pathologies: ampullary tumors, pericholecystic fluid, liver abscess Can visualize other pathologies- cholangitis: diverticuliits, pyelonephritis, mesenteric

ischemia, ruptured appendix Disadvantages

Sensitivity to contrast Poor imaging of gallstones

Med.virgina.edu

Soto et al. J. Roenterology. 2000

Page 10: cholangitis

Diagnostic: MRCP and ERCP

Magnetic resonance cholangiopancreatography (MRCP) Advantage

Detects choledocholithiasis, neoplasms, strictures, biliary dilations Sensitivity of 81-100%, specificity of 92-100% of

choledocholithiasis Minimally invasive- avoid invasive procedure in 50% of patients

Disadvantage: cannot sample bile, test cytology, remove stone Contraindications: pacemaker, implants, prosthetic valves

Indications If cholangitis not severe, and risk of ERCP high, MRCP useful If Charcot’s triad present, therapeutic ERCP with drainage should

not be delayed.Endoscopic retrograde cholangiopancreatography (ERCP) Gold standard for diagnosis of CBD stones, pancreatitis, tumors,

sphincter of Oddi dysfunction Advantage

Therapeutic option when CBD stone identified Stone retrieval and sphincterotomy

Disadvantage Complications: pancreatitis, cholangitis, perforation of duodenum

or bile duct, bleeding Diagnostic ERCP complication rate 1.38% , mortality rate 0.21%

Page 11: cholangitis

Medical Treatment Resucitate, Monitor, Stabilize if patient unstable

Consider cholangitis in all patients with sepsis

Antibiotics Empiric broad-spectrum Abx after blood cultures drawn

Ampicillin (2g/4h IV) plus gentamicin (4-6mg/kg IV daily) Carbapenems: gram negative, enterococcus, anaerobes Levofloxacin (250-500mgIV qD) for impaired renal fxn.

- 80% of patients can be managed conservatively 12-24 hrs Abx

- If fail medical therapy, mortality rate 100% without surgical decompression: ERCP or open

- Indication: persistent pain, hypotension, fever, mental confusion

Page 12: cholangitis

Surgical treatment Endoscopic biliary drainage

Endoscopic sphincterotomy with stone extraction and stent insertion

CBD stones removed in 90-95% of cases

Therapeutic mortality 4.7% and morbidity 10%, lower than surgical decompression

Surgery Emergency surgery replaced by non-

operative biliary drainage Once acute cholangitis controlled, surgical

exploration of CBD for difficult stone removal Elective surgery: low M & M compared with

emergency survey If emergent surgery, choledochotomy carries

lower M&M compared with cholecystectomy with CBD exploration

Page 13: cholangitis

Our case… Condition:

No acute distress, reasonably soft abdomen

ERCP attempted Duct unable to cannulate due to presence of duodenum diverticulum at site

of ampulla of Vater

Laparoscopic cholecystectomy planned Dissection of triangle of Calot Cystic duct and artery visualized and dissected Cystic duct ductotomy Insertion of cholangiogram catheter advanced and contrast bolused into

cystic duct for IOC

Intraoperative cholangiogram Several common duct filling defects consistent with stones Decision to proceed with CBD exploration